Loading...
BioNTech SE
BNTX•NASDAQ
HealthcareBiotechnology
$108.49
$-1.66(-1.51%)
BioNTech SE (BNTX) Financial Performance & Statements
Review BioNTech SE’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-27.96%
↓ 27.96%
Operating Income Growth
-290.37%
↓ 290.37%
Net Income Growth
-171.51%
↓ 171.51%
Operating Cash Flow Growth
-96.13%
↓ 96.13%
Operating Margin
-48.84%
↓ 48.84%
Gross Margin
78.87%
↑ 78.87%
Net Profit Margin
-27.99%
↓ 27.99%
ROE
-4.02%
↓ 4.02%
ROIC
-6.83%
↓ 6.83%
BioNTech SE (BNTX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for BioNTech SE stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.19B | $1.23B | $129.35M | $188.70M |
| Cost of Revenue | $243.50M | $176.51M | $60.10M | $59.45M |
| Gross Profit | $946.50M | $1.05B | $69.25M | $129.26M |
| Gross Profit Ratio | $0.80 | $0.86 | $0.54 | $0.68 |
| R&D Expenses | $611.80M | $542.95M | $587.56M | $510.49M |
| SG&A Expenses | $132.10M | $150.50M | $184.73M | $133.38M |
| Operating Expenses | $797.90M | $1.06B | $772.29M | $643.87M |
| Total Costs & Expenses | $1.04B | $1.23B | $832.39M | $703.32M |
| Interest Income | $0.00 | $156.20M | $167.70M | $180.10M |
| Interest Expense | $0.00 | $8.00M | $7.30M | $4.70M |
| Depreciation & Amortization | $165.40M | $44.40M | $50.15M | $38.53M |
| EBITDA | $480.79M | $211.10M | -$752.39M | -$290.50M |
| EBITDA Ratio | $0.40 | $0.17 | -$5.82 | -$1.54 |
| Operating Income | $148.60M | $10.50M | -$703.04M | -$514.61M |
| Operating Income Ratio | $0.12 | $0.009 | -$5.44 | -$2.73 |
| Other Income/Expenses (Net) | $152.60M | $146.08M | $160.40M | $175.40M |
| Income Before Tax | $301.20M | $156.58M | -$809.88M | -$333.75M |
| Income Before Tax Ratio | $0.25 | $0.13 | -$6.26 | -$1.77 |
| Income Tax Expense | $41.70M | -$38.87M | $2.01M | -$16.80M |
| Net Income | $259.50M | $195.46M | -$811.89M | -$316.95M |
| Net Income Ratio | $0.22 | $0.16 | -$6.28 | -$1.68 |
| EPS | $1.08 | $0.83 | -$3.42 | -$1.32 |
| Diluted EPS | $1.08 | $0.81 | -$3.42 | -$1.32 |
| Weighted Avg Shares Outstanding | $240.28M | $239.74M | $237.73M | $240.53M |
| Weighted Avg Shares Outstanding (Diluted) | $240.28M | $244.57M | $237.73M | $240.53M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan